China · Delayed Price · Currency is CNY Elevation Oncology Statistics
Total Valuation
SHE:300537 has a market cap or net worth of CNY 5.23 billion. The enterprise value is 5.22 billion.
| Market Cap | 5.23B |
| Enterprise Value | 5.22B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300537 has 208.31 million shares outstanding. The number of shares has increased by 2.42% in one year.
| Current Share Class | 208.31M |
| Shares Outstanding | 208.31M |
| Shares Change (YoY) | +2.42% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 36.07% |
| Owned by Institutions (%) | 4.21% |
| Float | 133.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 89.68 |
| PS Ratio | 10.29 |
| PB Ratio | 6.80 |
| P/TBV Ratio | 7.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 71.25, with an EV/FCF ratio of -213.74.
| EV / Earnings | -140.13 |
| EV / Sales | 10.27 |
| EV / EBITDA | 71.25 |
| EV / EBIT | 146.13 |
| EV / FCF | -213.74 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.56 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 2.59 |
| Debt / FCF | -7.78 |
| Interest Coverage | 6.94 |
Financial Efficiency
Return on equity (ROE) is -4.62% and return on invested capital (ROIC) is 2.31%.
| Return on Equity (ROE) | -4.62% |
| Return on Assets (ROA) | 1.84% |
| Return on Invested Capital (ROIC) | 2.31% |
| Return on Capital Employed (ROCE) | 4.53% |
| Revenue Per Employee | 1.01M |
| Profits Per Employee | -73,746 |
| Employee Count | 505 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.65 |
Taxes
In the past 12 months, SHE:300537 has paid 33.22 million in taxes.
| Income Tax | 33.22M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.38% in the last 52 weeks. The beta is 0.30, so SHE:300537's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +57.38% |
| 50-Day Moving Average | 23.41 |
| 200-Day Moving Average | 20.05 |
| Relative Strength Index (RSI) | 49.96 |
| Average Volume (20 Days) | 21,121,484 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300537 had revenue of CNY 508.22 million and -37.24 million in losses. Loss per share was -0.19.
| Revenue | 508.22M |
| Gross Profit | 178.90M |
| Operating Income | 35.71M |
| Pretax Income | -2.94M |
| Net Income | -37.24M |
| EBITDA | 71.92M |
| EBIT | 35.71M |
| Loss Per Share | -0.19 |
Balance Sheet
The company has 209.00 million in cash and 189.91 million in debt, giving a net cash position of 19.09 million or 0.09 per share.
| Cash & Cash Equivalents | 209.00M |
| Total Debt | 189.91M |
| Net Cash | 19.09M |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 768.87M |
| Book Value Per Share | 3.80 |
| Working Capital | 230.27M |
Cash Flow
In the last 12 months, operating cash flow was -9.17 million and capital expenditures -15.24 million, giving a free cash flow of -24.42 million.
| Operating Cash Flow | -9.17M |
| Capital Expenditures | -15.24M |
| Free Cash Flow | -24.42M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 35.20%, with operating and profit margins of 7.03% and -7.33%.
| Gross Margin | 35.20% |
| Operating Margin | 7.03% |
| Pretax Margin | -0.58% |
| Profit Margin | -7.33% |
| EBITDA Margin | 14.15% |
| EBIT Margin | 7.03% |
| FCF Margin | n/a |
Dividends & Yields
SHE:300537 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.42% |
| Shareholder Yield | -2.42% |
| Earnings Yield | -0.71% |
| FCF Yield | -0.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 31, 2017. It was a forward split with a ratio of 1.6.
| Last Split Date | May 31, 2017 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:300537 has an Altman Z-Score of 5.21 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.21 |
| Piotroski F-Score | 2 |